Anthony Strzalek
ABRE 36-month results show sustained patency and clinical improvements in complex...
Stephen Black (London, UK) talks to Venous News about the key 36-month results from the ABRE study, which evaluated the safety and effectiveness of the Abre venous...
Iliac side branch devices a “gamechanger” in AAA treatment
NOTE: This video is ONLY available to watch in selected countries and geographies
Iliac side branch devices (ISBs) are “gamechangers in infrarenal therapy of...
New mechanical thrombectomy systems unlock possibilities for the treatment of venous...
Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14...
Ovarian vein transposition to the iliac vein can significantly improve quality...
John White (Chicago, USA) talks to Venous News at this year’s European Society for Vascular Surgery annual meeting (ESVS 2022; 20–23 September, Rome, Italy),...
Why ClotTriever is a “gamechanger” for the treatment of deep vein...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) discuss the current state of deep vein thrombosis (DVT) treatment at the Leipzig Interventional...
Akura Medical closes US$25M Series A1 funding round
Akura Medical has announced the closing of its $25M Series A1 financing, which will be used to support the development of its next-generation thrombectomy device.
The financing...
Use of non-medical staff should be considered to address “sorry state”...
Venous care in the UK is in a “sorry state at the moment”, Zola Mzimba (Derry, UK) tells Venous News. This is in part down...
Recruitment underway for VenUS-6 trial on venous leg ulcer treatments
Catherine Arundel (York, UK) talks to Venous News at the UK Vascular Societies’ Annual Scientific Meeting (VSASM 2021; 1–3 December, Manchester, UK) about the...
VIVO 12-month results show “very good early success, excellent safety and...
Anthony Comerota (Alexandria, USA), global principal investigator of the VIVO trial, discusses the highlights of the 12-month results of the VIVO clinical study that...
CLEAR-DVT highlights “real paradigm shift” in treatment of DVT patients
Venous News takes a look back at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) where Stephen Black (London, UK) and Mitchell Silver (Columbus, USA) discuss the CLEAR-DVT study.
Silver touches...
VeClose five-year data give confidence about long-term durability of VenaSeal treatment
Kathleen Gibson (Bellevue, USA) put the five-year data from the VeClose study, which looked at the treatment of patients with venous reflux in the...
Telehealth ‘will change the future of venous practice’ post COVID-19
Six venous specialists, Manj Gohel (Cambridge, UK), Ian Franklin (London, UK) Alun Davies (London, UK), Sriram Narayanan (Singapore), Raghu Kolluri (Columbus, USA) and Stephen...
Thrombosis is major by-product of infection with COVID-19, but evidence to...
Manj Gohel (Cambridge, UK), one of the editors-in-chief of Venous News, introduces a special COVID-19 video with leading thrombosis and haemostasis experts, including Beverley...
First look at CLOUT registry reveals over 75% of DVT patients...
David J. Dexter, (Sentara Healthcare, Norfolk, VA, USA), principal investigator of the CLOUT registry using the ClotTriever Mechanical Thrombectomy System (Inari Medical) for treatment...
The new Venovo Venous Stent is changing clinical practice
Steven Dubenec (Sydney, Australia) and Gerard O’Sullivan (Galway, Ireland) discuss the impact of dedicated venous stents, in particular the Venovo venous stent (BD, formerly...